VIP syndrome: when access to everything shortens a life

Michael Jackson had something very few people in the world can afford: a full-time personal physician, living in, available at any hour. He died at 50, in 2009, of propofol intoxication — an operating-room anesthetic — given in his own bedroom to help him sleep. He did not die in spite of access to the "best" care. He died, in large part, because of it.

The story repeats itself with other names — Elvis Presley, Joan Rivers, Matthew Perry — and follows a pattern so consistent that medicine named it more than sixty years ago. This article explains that pattern, why it is not exclusive to the famous, and how the same logic shows up, on a smaller scale, in the check-up with dozens of tests, the high-dose vitamin protocol and the "hormone modulation" sold as premium care.

The phenomenon has a name: VIP syndrome

In 1964, the American psychiatrist Walter Weintraub described what happened in his hospital when the patient was someone influential: routine broke down, staff gave in to demands they would accept from no one else — and outcomes got worse. In the case series he published, 10 of the 12 "important" patients had therapeutic failures. He called it VIP syndrome (*very important person*).

The current definition is straightforward: a VIP is a patient whose attributes — fame, money, power, position — together with their behavior, have the potential to influence the physician's judgment. Celebrities, politicians, major donors and physicians themselves can all occupy that place. The problem is not that the person is important. It is the physician no longer practicing the medicine they would practice with any other patient. Not by chance, the first of the nine principles the Cleveland Clinic published in 2011 for the care of VIPs is, literally, "don't bend the rules."

The syndrome takes two forms, often at the same time:

• Doing too much: tests, procedures and prescriptions that would not be indicated for anyone else — because the patient asked, because they can pay, or because "it doesn't hurt to look."
• Doing too little: failing to say no, to confront an addiction, to refer to proper treatment — because crossing someone powerful has a cost for the caregiver.

Four deaths, one pattern

The cases below are public and were investigated by authorities. The aim is not to judge those who died — several of them lived with substance use disorders, which are diseases — but to understand what failed in the care they received.

Elvis Presley (1977, age 42)

The autopsy showed no obvious cause. Two months later, toxicology found 14 drugs in his system, among them codeine at about ten times the therapeutic level, methaqualone in a toxic amount, morphine, meperidine, diazepam and barbiturates. None of them alone explains the death; the combination of central nervous system depressants does. It is the picture of polypharmacy the literature describes in famous patients: several physicians, several pharmacies and, at times, aliases to obtain prescriptions.

Michael Jackson (2009, age 50)

His personal physician, a cardiologist, gave him propofol at home, at night, as a "sleep aid" — a use with no indication, outside any properly monitored setting — together with benzodiazepines such as lorazepam and midazolam. The coroner ruled the death a homicide from acute propofol intoxication with benzodiazepine effect. The physician was convicted of involuntary manslaughter and served two years in prison.

Joan Rivers (2014, age 81)

The comedian went to a New York clinic for an elective endoscopy. Once she was sedated with propofol, her personal ear, nose and throat physician — who had no privileges at that clinic — performed a laryngoscopy for which there was no documented consent. The US federal investigation also found that staff failed to identify her deteriorating vital signs, that the propofol dose was recorded inconsistently and that a photo of the sedated patient was taken with a cell phone during the procedure. She went into hypoxic arrest and died a week later. One extra procedure, performed by a physician who was in the room because she was a famous patient's personal doctor.

Matthew Perry (2023, age 54)

The actor, who spoke publicly about decades of addiction, was taking prescribed ketamine for depression. When his regular physician refused to raise the doses, he found another one willing to sell. That second physician admitted supplying 20 vials of ketamine plus lozenges and syringes and was sentenced to 30 months in prison in December 2025; in text messages, he wondered how much the actor would pay. The judge noted that the fatal dose came from another source — and that he had nonetheless helped feed the addiction that led to it.

What these stories have in common

None of them is about lack of access. All of them are about access without brakes. The same elements recur:

• The physician who becomes an employee. When the patient pays directly for a full-time physician, the relationship inverts: saying no starts to threaten the job.
• The standard of care suspended. An operating-room anesthetic in the bedroom, a procedure without consent, a prescription in someone else's name. Each of these would be unthinkable with an ordinary patient.
• Nobody coordinating. Several physicians, several prescriptions and no one responsible for seeing the whole — the ideal ground for the interaction that kills.
• The purchased "yes." In every case, the patient got what they asked for. What nobody bought was someone with the autonomy to refuse.

Money and access alone do not guarantee good care. What protects the patient is a physician who practices the same medicine for everyone — including when that means contradicting whoever is paying.

The everyday version: too many tests, too many vitamins

Most people will never have a physician living in their house. But the logic of VIP syndrome — "if I can pay, more is better" — sustains an entire market: the executive check-up with dozens of tests, the high-dose supplement protocol, "hormone modulation." The harm is less dramatic than in the cases above and, precisely for that reason, goes unnoticed.

Tests without an indication. A Cochrane review of more than 233,000 adults found no effect of general health checks on mortality. What a test without an indication usually produces is something else: a false positive, an incidental finding and the cascade of tests and procedures to clarify it — sometimes ending in a biopsy or surgery that did not need to happen. The article on routine tests on this site details that mechanism with numbers.

Vitamins and supplements. The idea that vitamins "can't hurt" did not survive clinical trials. Beta carotene increased lung cancer incidence — and total mortality — in smokers; high-dose vitamin E increased the risk of prostate cancer in healthy men; high daily-dose vitamin D, tested in almost 26,000 adults, did not reduce cancer or cardiovascular events. The US Preventive Services Task Force (USPSTF) recommends against beta carotene and vitamin E for prevention and finds the evidence insufficient to recommend multivitamins.

When the dose leaves the reasonable range, the harm stops being statistical. In a case published in 2021 by physicians in Paraná, Brazil, a 67-year-old woman with no prior disease was given, by a non-physician practitioner, compounded "hormone modulation" formulas adding up to about 700,000 units of vitamin D per week. She reached the hospital after months of nausea, vomiting, weakness and weight loss, with vitamin D above 210 ng/mL, calcium of 12.9 mg/dL and acute kidney injury, and had to be admitted.

Hormones "to stop aging." Brazil's Federal Council of Medicine has prohibited, since 2012, hormone therapies intended to delay, modulate or prevent aging and, since 2023, prescribing anabolic steroids for aesthetic or performance purposes. In 2024, Anvisa, the national health regulator, banned compounded hormone implants for those purposes — the so-called "beauty chips." Hormone replacement remains indicated when there is a proven deficiency; what has no support is treating lab numbers in people without disease.

None of this means supplements have no place. Vitamin D in osteoporosis or in documented deficiency with risk factors, folic acid before and early in pregnancy, B12 in deficiency, iron in iron-deficiency anemia — all have clear indications. The error is the same as in the famous cases: treating the absence of an indication as if it were extra care.

The antidote has a name too: quaternary prevention

Family Medicine has a concept created precisely for this. Proposed by the Belgian family physician Marc Jamoulle and adopted by WONCA, the world organization of family doctors, quaternary prevention means identifying people at risk of overmedicalization and protecting them from unnecessary interventions. It is the practical form of *primum non nocere* — first, do no harm.

In the consultation, it translates into simple rules that apply to every patient:

• Every test must answer a question. If the result changes no decision, it should not be ordered.
• Every prescription needs an indication. "It can't hurt" is not an indication.
• Someone has to see the whole. A physician who coordinates care, knows every medication and supplement in use and can say when something is too much.
• The standard is the same for everyone. There is no medicine for those who pay more. There is the medicine the evidence supports.

For the patient

Before accepting a test, a supplement protocol or a "complete check-up," four questions help:

• What changes if the result comes back abnormal? If the answer is "nothing" or "more tests to confirm," the test probably doesn't need to be done.
• What is the evidence that this improves my health — not a lab number, but my life: less disease, fewer hospital stays, more time?
• Who is looking at all my medications and supplements at the same time?
• Am I paying for care or for a "yes"? A good physician is also one who, sometimes, recommends not doing.

People with unlimited access died of excess, not of lack. The care that protects is not the one that does everything. It is the one that knows what not to do.